Teva Pharmaceutical Industries Ltd (TEVA)
$12.84 0.09 (0.71%)
19:57 EDT TEVA Stock Quote Delayed 30 Minutes
Previous Close $12.84
Market Cap 13.08B
PE Ratio -0.81
Volume (Avg. Vol.) 7.27M
Day's Range 12.78 - 13.08
52-Week Range 6.07 - 13.76
Dividend & Yield 0.07 (0.56%)
TEVA Stock Predictions, Articles, and Teva Pharmaceutical Industries Ltd News
- From InvestorPlace
- From the Web
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
By Thomas Niel
With shares rebounded, now may not be the time to enter Teva stock. Wait to see how upcoming opioid trials play out. If shares pull back to prior price levels, a buying opportunity may emerge. But for now, the risks do not match up with potential upside.
Teva stock has rallied from its lows on optimism toward legal settlements. But the balance sheet of TEVA remains an enormous risk.
Teva Pharmaceuticals is under the glare of legal and regulatory scrutiny. However, TEVA will eventually find its way because frankly, it has to.
For risk-averse investors, TEVA stock has many questions that make it a rough pick. But for the hardened speculator, it might be worth a shot.
By David Moadel
TEVA stock has earned its reputation - and I mean that in the worst possible way.
The U.S.-China trade war is weighing on these large-cap stocks to sell. Volatile oil prices and the opioid crisis aren't helping, either.
Despite the rally, Teva stock is inexpensive. The company is working on paying off its debt and building a strong generics portfolio.
Palo Alto Networks, Burlington Stores, Teva and Disney are our top stock trades to watch going into Wednesday.
Over the past year, healthcare stocks generally lagged as markets rebounded. That's changing though, starting with these three names.
By Thomas Niel
The TEVA stock price has rebounded on a potential opioid settlement. But consider the company's other risks before buying Teva.
Teva stock fell sharply this year in large part thanks to the opioid crisis, but with a last-minute deal, shares look more interesting now.
Another opioid settlement has been reached and earnings season is heating up. Here's what happened in the stock market today.
Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.
Warren Buffett saw a few of his top holdings take a hit this week. Here's what happened in the stock market today.
Teva, Take-Two, Beyond Meat, PaySign and Sogou were our top stock trades on Tuesday. Here's how to trade them.
From Market News Video
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader